AGILENT TECHNOLOGIES INC

NYSE: A (Agilent Technologies, Inc.)

Last update: 24 Sep, 11:33PM

124.38

-1.56 (-1.24%)

Previous Close 125.94
Open 125.17
Volume 1,239,904
Avg. Volume (3M) 1,669,495
Market Cap 35,261,779,968
Price / Earnings (TTM) 29.06
Price / Earnings (Forward) 22.94
Price / Sales 5.82
Price / Book 6.17
52 Weeks Range
96.43 (-22%) — 153.84 (23%)
Earnings Date 24 Nov 2025
TTM Dividend Yield 0.40%
Profit Margin 17.59%
Operating Margin (TTM) 23.56%
Diluted EPS (TTM) 4.06
Quarterly Revenue Growth (YOY) 6.00%
Quarterly Earnings Growth (YOY) -30.20%
Total Debt/Equity (MRQ) 60.04%
Current Ratio (MRQ) 2.09
Operating Cash Flow (TTM) 1.58 B
Levered Free Cash Flow (TTM) 1.05 B
Return on Assets (TTM) 8.46%
Return on Equity (TTM) 18.88%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bullish Mixed
Diagnostics & Research (Global) Bullish Mixed
Stock Agilent Technologies, Inc. Bullish Bullish

AIStockmoo Score

2.5
Analyst Consensus 4.0
Insider Activity NA
Price Volatility 1.0
Technical Moving Averages 1.0
Technical Oscillators 4.0
Average 2.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
A 35 B 0.40% 29.06 6.17
IQV 30 B - 25.90 6.01
MTD 26 B - 31.55 -
WAT 17 B - 26.36 8.87
RVTY 11 B 0.23% 38.54 1.40
DHR 133 B 0.32% 39.56 2.88

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Mid Core
% Held by Insiders 0.29%
% Held by Institutions 91.53%
52 Weeks Range
96.43 (-22%) — 153.84 (23%)
Price Target Range
140.00 (12%) — 170.00 (36%)
High 170.00 (UBS, 36.68%) Buy
Median 156.00 (25.42%)
Low 140.00 (Evercore ISI Group, 12.56%) Hold
Average 155.50 (25.02%)
Total 6 Buy, 2 Hold
Avg. Price @ Call 135.95
Firm Date Target Price Call Price @ Call
TD Cowen 14 Oct 2025 162.00 (30.25%) Buy 138.04
JP Morgan 09 Oct 2025 165.00 (32.66%) Buy 140.11
Rothschild & Co 08 Oct 2025 165.00 (32.66%) Buy 140.81
UBS 08 Oct 2025 170.00 (36.68%) Buy 140.81
Evercore ISI Group 07 Oct 2025 140.00 (12.56%) Hold 138.56
28 Aug 2025 128.00 (2.91%) Hold 124.96
Barclays 02 Oct 2025 150.00 (20.60%) Hold 138.70
02 Oct 2025 150.00 (20.60%) Hold 138.70
Wells Fargo 15 Sep 2025 150.00 (20.60%) Buy 125.63
28 Aug 2025 140.00 (12.56%) Buy 124.96
Baird 28 Aug 2025 142.00 (14.17%) Buy 124.96
Show more

No data within this time range.

Date Type Details
30 Sep 2025 Announcement Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening
29 Sep 2025 Announcement Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing
22 Sep 2025 Announcement Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine
17 Sep 2025 Announcement Agilent Announces Cash Dividend of 24.8 Cents per Share
11 Sep 2025 Announcement Agilent to Participate in 2025 Bank of America Global Healthcare Conference
09 Sep 2025 Announcement Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification
03 Sep 2025 Announcement Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025
02 Sep 2025 Announcement Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer
27 Aug 2025 Announcement Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results
21 Aug 2025 Announcement Agilent to Participate in 2025 Wells Fargo Healthcare Conference
20 Aug 2025 Announcement Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer
13 Aug 2025 Announcement Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment
04 Aug 2025 Announcement Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs
17 Jul 2025 Announcement Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27
Show more
TTM Dividend Yield 0.40%
5Y Average Dividend Yield 0.60%
Payout Ratio 23.84%
Expected Next Dividend Payment Jan 2026
Ex Date Announcement Date Payment Date Details
01 Apr 2025 19 Feb 2025 23 Apr 2025 0.248 Cash
31 Dec 2024 20 Nov 2024 22 Jan 2025 0.248 Cash
01 Oct 2024 18 Sep 2024 23 Oct 2024 0.236 Cash
02 Jul 2024 22 May 2024 24 Jul 2024 0.236 Cash
01 Apr 2024 21 Feb 2024 24 Apr 2024 0.236 Cash
29 Dec 2023 15 Nov 2023 24 Jan 2024 0.236 Cash
02 Oct 2023 20 Sep 2023 25 Oct 2023 0.225 Cash
30 Jun 2023 17 May 2023 26 Jul 2023 0.225 Cash
03 Apr 2023 22 Feb 2023 26 Apr 2023 0.225 Cash
30 Dec 2022 16 Nov 2022 25 Jan 2023 0.225 Cash
03 Oct 2022 21 Sep 2022 26 Oct 2022 0.21 Cash
01 Jul 2022 18 May 2022 27 Jul 2022 0.21 Cash
04 Apr 2022 15 Feb 2022 27 Apr 2022 0.21 Cash
03 Jan 2022 17 Nov 2021 26 Jan 2022 0.21 Cash
04 Oct 2021 22 Sep 2021 27 Oct 2021 0.194 Cash
02 Jul 2021 19 May 2021 28 Jul 2021 0.194 Cash
05 Apr 2021 17 Mar 2021 28 Apr 2021 0.194 Cash
04 Jan 2021 18 Nov 2020 27 Jan 2021 0.194 Cash
05 Oct 2020 16 Sep 2020 28 Oct 2020 0.18 Cash
29 Jun 2020 20 May 2020 22 Jul 2020 0.18 Cash
30 Mar 2020 18 Mar 2020 22 Apr 2020 0.18 Cash
30 Dec 2019 21 Nov 2019 22 Jan 2020 0.18 Cash
30 Sep 2019 19 Sep 2019 23 Oct 2019 0.164 Cash
01 Jul 2019 23 May 2019 24 Jul 2019 0.164 Cash
01 Apr 2019 21 Mar 2019 24 Apr 2019 0.164 Cash
28 Dec 2018 15 Nov 2018 23 Jan 2019 0.164 Cash
01 Oct 2018 20 Sep 2018 24 Oct 2018 0.149 Cash
02 Jul 2018 17 May 2018 25 Jul 2018 0.149 Cash
02 Apr 2018 21 Mar 2018 25 Apr 2018 0.149 Cash
29 Dec 2017 15 Nov 2017 24 Jan 2018 0.149 Cash
02 Oct 2017 20 Sep 2017 25 Oct 2017 0.132 Cash
29 Jun 2017 17 May 2017 26 Jul 2017 0.132 Cash
31 Mar 2017 15 Mar 2017 26 Apr 2017 0.132 Cash
29 Dec 2016 17 Nov 2016 25 Jan 2017 0.132 Cash
30 Sep 2016 21 Sep 2016 26 Oct 2016 0.115 Cash
30 Jun 2016 18 May 2016 27 Jul 2016 0.115 Cash
01 Apr 2016 16 Mar 2016 27 Apr 2016 0.115 Cash
31 Dec 2015 19 Nov 2015 27 Jan 2016 0.115 Cash
25 Sep 2015 16 Sep 2015 21 Oct 2015 0.1 Cash
26 Jun 2015 20 May 2015 22 Jul 2015 0.1 Cash
27 Mar 2015 18 Mar 2015 22 Apr 2015 0.1 Cash
02 Jan 2015 20 Nov 2014 28 Jan 2015 0.1 Cash
26 Sep 2014 17 Sep 2014 22 Oct 2014 0.094 Cash
27 Jun 2014 22 May 2014 23 Jul 2014 0.094 Cash
09 Apr 2014 01 Apr 2014 23 Apr 2014 0.094 Cash
27 Dec 2013 22 Nov 2013 22 Jan 2014 0.094 Cash
27 Sep 2013 18 Sep 2013 23 Oct 2013 0.086 Cash
28 Jun 2013 23 May 2013 24 Jul 2013 0.086 Cash
28 Mar 2013 17 Jan 2013 24 Apr 2013 0.086 Cash
27 Dec 2012 16 Nov 2012 23 Jan 2013 0.071 Cash
28 Sep 2012 20 Sep 2012 24 Oct 2012 0.071 Cash
29 Jun 2012 16 May 2012 25 Jul 2012 0.071 Cash
30 Mar 2012 17 Jan 2012 25 Apr 2012 0.071 Cash
01 Nov 2006 - 31 Oct 2006 2.057 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2025 0.496 2 0.40
2024 0.944 4 0.70
2023 0.900 4 0.65
2022 0.840 4 0.56
2021 0.776 4 0.49
2020 0.720 4 0.61
2019 0.656 4 0.77
2018 0.596 4 0.88
2017 0.528 4 0.79
2016 0.460 4 1.01
2015 0.400 4 0.96
2014 0.376 4 0.92
2013 0.329 4 0.80
2012 0.213 3 0.73
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria